These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6325006)

  • 1. Activity of third-generation cephalosporins in human blood.
    Shah PM; Jaenisch E
    Clin Ther; 1983; 6(1):72-8. PubMed ID: 6325006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro and in-vivo efficacy of ceftriaxone, moxalactam, and chloramphenicol against Haemophilus influenzae type b.
    Connor E; Melick C; Yogev R
    J Antimicrob Chemother; 1982 Dec; 10(6):517-25. PubMed ID: 6298172
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
    Saito M; Azuma K; Nishino T; Tanino T
    Jpn J Antibiot; 1983 Oct; 36(10):2833-43. PubMed ID: 6325746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
    Jones RN; Wilson HW
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
    Jarlier V; Bismuth R; Grosset J
    Pathol Biol (Paris); 1983 May; 31(5):336-42. PubMed ID: 6312393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime.
    McNamee W; Drusano GL; Tatem BA; Standiford HC
    J Antimicrob Chemother; 1984 Nov; 14(5):491-7. PubMed ID: 6096348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of storage temperature and time on stability of cefmenoxime, ceftriaxone, and cefotetan in 5% dextrose injection.
    Smith BR
    Am J Hosp Pharm; 1983 Jun; 40(6):1024-5. PubMed ID: 6307045
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus.
    Lagast H; Zinner SH; Klastersky J
    Antimicrob Agents Chemother; 1981 Oct; 20(4):539-41. PubMed ID: 6282198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactivity of cefotetan and ceftriaxone antibodies, associated with hemolytic anemia, with other: cephalosporins and penicillin.
    Arndt PA; Garratty G
    Am J Clin Pathol; 2002 Aug; 118(2):256-62. PubMed ID: 12162687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the in vitro activity of cefotetan on bacterial strains of recent hospital isolation].
    Lembo M; Nani E; Covelli I; Anzivino D; Gulletta E
    G Batteriol Virol Immunol; 1985; 78(7-12):224-44. PubMed ID: 3870426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime.
    Wise R; Andrews JM
    Eur J Clin Microbiol; 1983 Oct; 2(5):505-8. PubMed ID: 6315427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vivo antibacterial activity of cefbuperazone. Synergy of cefbuperazone for bactericidal effect with human polymorphonuclear leukocytes].
    Kumasaka Y; Nakahata H; Hirai Y; Imamura K; Takebe K; Suzuki I; Senda H
    Jpn J Antibiot; 1986 Jan; 39(1):154-8. PubMed ID: 3517405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Timed bacteriostatic and bactericidal activities of latamoxef against clinical strains of gram-negative bacteria].
    Masuda G; Negishi M; Young C; Mukaiyama T; Hanai N; Uchikawa S; Thoma T; Yamazaki E
    Jpn J Antibiot; 1983 Jan; 36(1):16-21. PubMed ID: 6221128
    [No Abstract]   [Full Text] [Related]  

  • 17. The cephalosporin antibiotic agents--III. Third-generation cephalosporins.
    Marsh TD
    Infect Control; 1985 Feb; 6(2):78-83. PubMed ID: 3882594
    [No Abstract]   [Full Text] [Related]  

  • 18. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects.
    Barriere SL; Ozasa DC; Mordenti J
    Antimicrob Agents Chemother; 1985 Jul; 28(1):55-7. PubMed ID: 3929680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of Sch 29482, MK 0787, ceftriaxone and seven other antimicrobials against 840 separate clinical isolates.
    Pierson CL; Schaberg DR; Fekety FR; McClatchey KD
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():79-89. PubMed ID: 6277844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.